Oxford University
Wellington Square
Oxford
OX1 2JD
United Kingdom
Tel: 44-1865-270000
Fax: +44-1865-270708
Website: http://www.ox.ac.uk/
187 articles with Oxford University
-
Medidata and Oxford University Innovation’s Clinical Outcomes Team Announce Addition of Gold Standard Questionnaires to eCOA Library
11/12/2020
Medidata and its customers gain access to pre-configured, pre-approved questionnaires in multiple languages to support clinical study start-up, quality, and efficiency
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 14, 2020.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 7, 2020.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 3, 2020.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 22, 2020.
-
Oxford University, which by many standards is ahead of everyone in the vaccine development world, is suggesting end of the year is possible, but being very cautious about it.
-
Clinical Catch-Up: July 13-17
7/20/2020
It was a surprisingly big week for clinical trial updates related to COVID-19, although there was plenty of non-COVID-19 news as well. Here’s a look. -
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 20, 2020.
-
AstraZeneca’s COVID-19 vaccine candidate induced significant immune responses in the majority of patients following a single dose in a Phase I study. The preventative medication also proved to be fairly safe, study results showed.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 17, 2020.
-
Report: AstraZeneca's COVID-19 Vaccine Generates Antibodies and T-Cells Against the Virus in Phas...
7/16/2020
Phase I data from the COVID-19 vaccine under development by AstraZeneca and Oxford University’s Jenner Institute is showing a robust defense against the novel coronavirus that has infected more than 13 million people across the globe. -
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 15, 2020.
-
Dexamethasone Reduces Deaths in Hospitalized COVID-19 Patients Needing Oxygen, Study Shows
6/16/2020
Low doses of a long-used steroid known as dexamethasone could be the solution to improving the chances of patients who become seriously ill from COVID-19 infection and require some kind of breathing assistance. -
Less than one month after the White House zeroed in on 14 vaccine candidates for COVID-19, the administration has narrowed that list even more to five potential treatments for the prevention of the novel coronavirus.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 21, 2020.
-
With emergency approval, the Oxford University researchers believe they could have a few million doses of the vaccine available by September if it is proven effective.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 28, 2020.
-
Cobra Biologics is proud to be part of a consortium to rapidly develop a COVID-19 vaccine
3/31/2020
Keele, UK, 31 March 2020: Cobra Biologics, an international CDMO for biologics and pharmaceuticals, announced it is working as part of a consortium led by the Jenner Institute, Oxford University to rapidly develop, scale-up and produce the potential adenoviral vaccine candidate, ChAdOx1 nCov-19, for fast-tracked clinical trials for COVID-19.
-
Bicycle Therapeutics Expands Neuroscience Collaborations to Include Oxford University’s Oxford Drug Discovery Institute
10/22/2019
Bicycle to collaborate with ODDI, an organization with deep expertise in the molecular pathology of Alzheimer’s disease and CNS drug development
-
Crescendo Biologics to collaborate with world-leading oncology groups at the University of Oxford and the University of Surrey
9/12/2019
Crescendo Biologics Ltd announces that it has signed collaborations with world-renowned oncology research groups at the University of Oxford and the University of Surrey.